Flagship Labs 103, Inc. (FL103) is an early-stage company developing advanced molecular technologies for early disease detection using minimally invasive biospecimens. They aim to enable earlier disease detection, longitudinal disease monitoring, and improved patient stratification across oncology, neurodegenerative disease, and other major disease areas. FL103 was founded by Flagship Pioneering, an innovation enterprise focused on creating companies with breakthrough technologies. This role is a foundational position to translate early assay and biological discoveries into robust, scalable, and clinically meaningful diagnostic assays. The individual will drive the development and optimization of highly multiplexed molecular assays for plasma-based applications, focusing on improving assay sensitivity, specificity, reproducibility, and analytical performance. The role requires deep expertise in translational assay development within molecular diagnostics, liquid biopsy, or advanced biomarker platforms, and the ability to convert complex biological signals into deployable diagnostic workflows. The ideal candidate will thrive in collaborative, fast-moving environments and act as a player-coach, remaining close to the science while building and mentoring a growing product development organization. This is an opportunity to join a Flagship-founded company at its earliest stages and help build a transformational diagnostic platform.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree